BRONTE, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 3.840
EU - Europa 1.450
AS - Asia 1.292
SA - Sud America 195
Continente sconosciuto - Info sul continente non disponibili 175
AF - Africa 37
OC - Oceania 2
Totale 6.991
Nazione #
US - Stati Uniti d'America 3.776
SG - Singapore 544
RU - Federazione Russa 401
IT - Italia 298
CN - Cina 284
FI - Finlandia 176
BR - Brasile 154
HK - Hong Kong 136
DE - Germania 120
VN - Vietnam 104
UA - Ucraina 89
GB - Regno Unito 73
PL - Polonia 73
FR - Francia 62
IE - Irlanda 55
IN - India 42
CA - Canada 37
BD - Bangladesh 34
JP - Giappone 33
TR - Turchia 25
SE - Svezia 23
KR - Corea 21
RO - Romania 16
BE - Belgio 13
EC - Ecuador 12
CI - Costa d'Avorio 11
AT - Austria 10
ES - Italia 10
NL - Olanda 10
AR - Argentina 9
ID - Indonesia 9
PK - Pakistan 9
MX - Messico 8
LT - Lituania 6
MY - Malesia 6
PH - Filippine 6
ZA - Sudafrica 6
CO - Colombia 5
NP - Nepal 5
SA - Arabia Saudita 5
CL - Cile 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
JM - Giamaica 4
KE - Kenya 4
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
CH - Svizzera 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
NI - Nicaragua 2
PE - Perù 2
PY - Paraguay 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KY - Cayman, isole 1
ML - Mali 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SV - El Salvador 1
Totale 6.818
Città #
Ashburn 480
Fairfield 454
Singapore 386
San Jose 235
Woodbridge 232
Chandler 218
Houston 206
Seattle 183
Wilmington 176
Cambridge 155
Ann Arbor 151
Hong Kong 131
Palermo 73
Council Bluffs 70
Moscow 63
Zgierz 60
Beijing 56
New York 56
Dublin 55
Los Angeles 51
Jacksonville 49
Medford 49
Altamura 45
Des Moines 42
Ho Chi Minh City 37
Boardman 35
Hanoi 34
Princeton 32
Tokyo 32
Lawrence 31
Nanjing 31
San Diego 29
Frankfurt am Main 28
The Dalles 27
Lauterbourg 26
Dallas 25
Helsinki 22
Santa Clara 22
Dearborn 17
Buffalo 16
Tulsa 16
Washington 16
Chicago 14
London 14
São Paulo 14
Phoenix 13
Brussels 12
Chennai 12
Orem 12
Abidjan 11
Izmir 11
Rome 11
Jiaxing 10
Nanchang 10
Shenyang 10
Atlanta 9
Milan 9
Changsha 8
Hebei 8
Hefei 8
Kumar 8
Ludwigshafen am Rhein 8
Paris 8
Toronto 8
Brooklyn 7
Ottawa 7
San Paolo di Civitate 7
Stockholm 7
Warsaw 7
Amsterdam 6
Belo Horizonte 6
Denver 6
Guangzhou 6
Haiphong 6
Jinan 6
Montreal 6
Munich 6
Napoli 6
Saint Petersburg 6
San Francisco 6
Zhengzhou 6
Istanbul 5
Johannesburg 5
Manchester 5
Norwalk 5
Nuremberg 5
Poplar 5
Rio de Janeiro 5
Bologna 4
Boston 4
Cagliari 4
Charlotte 4
Düsseldorf 4
Kingston 4
Nairobi 4
Nürnberg 4
Salt Lake City 4
Seoul 4
Shenzhen 4
Springfield 4
Totale 4.570
Nome #
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals 338
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 286
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis 284
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors 276
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis 273
Targeted Therapies in Hepatocellular Carcinoma 272
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 269
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. 255
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C 245
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 243
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. 237
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. 235
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 232
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C 230
STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD 229
HCV clearance among hemophiliacs and beta-thalassemics 218
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. 211
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis 211
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy 210
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. 209
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience 209
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis 206
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 206
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication? 196
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) 196
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis 186
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. 169
GENETIC, VIROLOGICAL AND CLINICAL FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA DEVELOPEMENT IN PATIENTS WITH CHRONIC HBV AND HCV INFECTION 169
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC 141
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene 129
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 113
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy 108
Totale 6.991
Categoria #
all - tutte 23.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022324 0 0 26 12 19 20 35 29 36 50 31 66
2022/2023558 51 138 6 69 58 84 33 29 49 2 24 15
2023/2024230 10 29 25 27 18 50 21 15 0 6 3 26
2024/2025549 13 25 19 49 30 15 51 32 38 54 92 131
2025/20262.296 148 63 114 201 252 371 338 216 165 240 100 88
2026/2027457 105 77 275 0 0 0 0 0 0 0 0 0
Totale 6.991